Inventia Healthcare recalls 13,567 chlorthalidone bottles after dissolution failure
AI Summary- Inventia Healthcare is voluntarily recalling chlorthalidone tablets after they failed dissolution specifications.
- 13,567 bottles from batch RISA24002 expire in April 2027 and were distributed nationwide.
- The FDA classified the recall as Class II on Sept. 17 after its Sept. 3 initiation.